Patent · US Active

Modified apidaecin derivatives as antibiotic peptides

US10435437B2 · kind B2 · utility

0Cited by

2References

25Claims

0Family size

Assignee

Universitaet Leipzig · DE

Inventors

Ralf Hoffmann
Daniel Knappe · Leipzig, DE
Kai Hilpert · Marbach am Neckar, DE
Ralf Mikut · Karlsruhe, DE
Serge Ruden · Pforzheim, DE

Key dates

Filing date	Dec 23, 2016
Grant date	Oct 8, 2019
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to modified antibiotic peptides, particularly for use in medicine. The invention further relates to composite and methods for destroying microorganisms, such as bacteria, viruses or fungi, and to methods for treating microbial infections. The object of the invention is to develop novel antibiotic peptides, particularly having enhanced antibiotic activity and an expanded spectrum of activity against other strains of bacteria, particularly gram-positive bacteria such as Staphylococcus aureus. According to the invention, the object is attained in a first aspect by a peptide according to claim 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.